Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 14
Tables & Figures: 200
Countries covered: 19
Pages: 170
Download Free PDF

Onychomycosis Treatment Market
Get a free sample of this reportGet a free sample of this report Onychomycosis Treatment Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Onychomycosis Treatment Market Size
The global onychomycosis treatment market was estimated at USD 4.2 billion in 2024. The market is expected to grow from USD 4.3 billion in 2025 to USD 6.9 billion in 2034, at a CAGR of 5.3%. The high growth of market is attributed to increasing prevalence of onychomycosis globally, growing awareness about the potential threats of onychomycosis, and the increase in adoption of drug therapies for the treatment of onychomycosis. In addition, the increasing cases of age-related onychomycosis will further contribute market growth during the analysis period.
The market is further strengthened by the growing popularity of online pharmacies and the rise in consumer preference for self-treatment, owing to increasing availability of over the counter (OTC) drugs for onychomycosis. E-commerce platforms such as Amazon and eBay, along with dedicated pharmacy websites and retail pharmaceutical stores, have made it easier for consumers to directly access antifungal drugs, contributing to market growth. Additionally, the increasing prevalence of diabetes raises the risk of onychomycosis, as diabetic patients are more susceptible to the condition due to compromised immune systems and poor circulation. For instance, with over 400 million people currently affected by diabetes, the demand for onychomycosis treatments within this patient group is rising, further driving market expansion.
Further, the rising geriatric population increases the risk of developing onychomycosis. Thus, with the rapidly growing aging population the incidence of nail fungal infection increases, that further contribute to market growth. As an example, the report published by United Nations states that the number of people aged 60 and above will double by 2050 to reach 2.1 billion. Moreover, increasing awareness and cosmetic concerns among consumers regarding nail infections are leading to a growing focus on the aesthetic care of hands and feet, thereby contributing to market growth.
Onychomycosis, also identified as tinea unguium, is a fungal infection of the fingernails or toenails that may comprise any component of the nail unit. The symptoms include thickening, discoloration, and separation from the nail bed. Onychomycosis treatment includes creams, medicated nail polish, and oral anti-fungal drugs. The high availability of different onychomycosis treatment options in the market will propel industry growth.
Onychomycosis Treatment Market Trends
Trump Administration Tariffs
Onychomycosis Treatment Market Analysis
In 2021, the global market was valued at USD 3.7 billion. The following year, it saw a slight increase to USD 3.8 billion, and by 2023, the market further climbed to USD 4 billion.
Based on treatment type, the global onychomycosis treatment market is divided into drugs, laser and photodynamic therapy and surgery. The drugs segment is further sub-segmented into oral antifungal drugs and topical antifungal drugs. The drugs segment dominated the market and was valued at USD 3.2 billion in 2024.
Based on the disease type, the global onychomycosis treatment market is categorized into distal subungual onychomycosis (DSO), proximal subungual onychomycosis (PSO), white superficial onychomycosis (WSO), and other disease types. The distal subungual onychomycosis segment accounted for the highest market share of 68.3% in 2024.
Based on the gender, the global onychomycosis treatment market is categorized into male and female. The female segment dominated the market in 2024 and is anticipated to grow with a significant CAGR of 5.2% during the analysis period.
Based on the end use, the global onychomycosis treatment market is categorized into hospitals, dermatology clinics, homecare settings, and ambulatory surgical centers. The dermatology clinics segment dominated the market in 2024 and is anticipated to reach USD 3 billion by 2034.
In 2024, the U.S. held a significant position in the North America onychomycosis treatment market and was valued at USD 1.6 billion.
Germany onychomycosis treatment market shows strong growth potential in the Europe market.
The onychomycosis treatment market in Asia Pacific is estimated to grow at a CAGR of 5.6% over the next few years.
Brazil's onychomycosis treatment market is projected to witness significant growth in Latin America market in the coming years.
Saudi Arabia onychomycosis treatment market is witnessing substantial growth in the Middle East and African market.
Onychomycosis Treatment Market Share
The top 5 companies in the market, such as Novartis, Pfizer, Bausch Health Sciences, Galderma Laboratories, and Dr. Reddy’s accounting for approximately 55% of the market share. Companies in the market maintain their competitive edge through innovations in diagnostic technologies, antifungal therapies, and AI-assisted healthcare solutions. With growing demand for specialized care, firms are expanding their portfolios to include precision diagnostic tools, advanced drug delivery systems, and personalized treatment regimens aimed at improving therapeutic efficacy and patient outcomes. For instance, leading players such as Bausch Health and Galderma are investing in next-generation topical and oral antifungals, while others focus on integrating AI-driven diagnostics and real-time treatment monitoring. These advancements are not only enhancing clinical accuracy but also accelerating market growth and intensifying competition across the sector. Companies are focusing on product differentiation, regulatory approvals, and strategic partnerships to strengthen their position in this competitive market.
Onychomycosis Treatment Market Companies
Few of the prominent players operating in the onychomycosis treatment industry include:
To stay competitive, key players are investing in research and development, partnerships, and collaborations to launch new onychomycosis solutions.
Onychomycosis Treatment Industry News
The onychomycosis treatment market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Treatment Type
Market, By Disease Type
Market, By Gender
Market, By End Use
The above information is provided for the following regions and countries: